- KR₩137bn
- KR₩136bn
- KR₩34bn
- 50
- 28
- 65
- 46
Annual balance sheet for Osteonic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 23,829 | 21,645 | 16,953 | 14,716 | 20,645 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 10,473 | 10,930 | 10,758 | 11,850 | 15,061 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 42,225 | 40,744 | 37,423 | 40,324 | 53,518 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 12,617 | 11,602 | 12,995 | 20,050 | 24,491 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 63,330 | 64,170 | 61,525 | 71,739 | 89,920 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 20,311 | 25,218 | 19,686 | 11,954 | 17,371 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 39,049 | 28,639 | 25,025 | 19,862 | 30,596 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Total Equity | 24,281 | 35,532 | 36,501 | 51,877 | 59,324 |
Total Liabilities & Shareholders' Equity | 63,330 | 64,170 | 61,525 | 71,739 | 89,920 |
Total Common Shares Outstanding |